HAWK and HARRIER: Phase 3, Multicenter,Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration |
| |
| Affiliation: | 1. Retinal Consultants of Arizona, Phoenix, Arizona; University of Southern California, Los Angeles, California;2. Eye & Retina Surgeons, Singapore;3. Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;4. Duke Eye Center, Durham, North Carolina;5. Medical University of Vienna, Vienna, Austria;6. Retina Consultants of Houston, Houston, Texas;7. University of Sao Paulo, Sao Paulo, Brazil;8. Novartis Pharma AG, Basel, Switzerland;9. University of Bonn, Bonn, Germany |
| |
| Abstract: | |
| |
| Keywords: | AMD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0015" }," $$" :[{" #name" :" text" ," _" :" age-related macular degeneration BCVA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0025" }," $$" :[{" #name" :" text" ," _" :" best-corrected visual acuity CI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0035" }," $$" :[{" #name" :" text" ," _" :" confidence interval CST" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" central subfield thickness IRF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" intraretinal fluid IRT" },{" #name" :" keyword" ," $" :{" id" :" kwrd0065" }," $$" :[{" #name" :" text" ," _" :" Interactive Response Technology LOCF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" last observation carried forward LS" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" least squares nAMD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" neovascular age-related macular degeneration PRN" },{" #name" :" keyword" ," $" :{" id" :" kwrd0105" }," $$" :[{" #name" :" text" ," _" :" pro re nata q8w" },{" #name" :" keyword" ," $" :{" id" :" kwrd0115" }," $$" :[{" #name" :" text" ," _" :" every 8 weeks q12w" },{" #name" :" keyword" ," $" :{" id" :" kwrd0125" }," $$" :[{" #name" :" text" ," _" :" every 12 weeks RPE" },{" #name" :" keyword" ," $" :{" id" :" kwrd0135" }," $$" :[{" #name" :" text" ," _" :" retinal pigment epithelium scFv" },{" #name" :" keyword" ," $" :{" id" :" kwrd0145" }," $$" :[{" #name" :" text" ," _" :" single-chain antibody fragments SRF" },{" #name" :" keyword" ," $" :{" id" :" kwrd0155" }," $$" :[{" #name" :" text" ," _" :" subretinal fluid VEGF-A" },{" #name" :" keyword" ," $" :{" id" :" kwrd0165" }," $$" :[{" #name" :" text" ," _" :" vascular endothelial growth factor A |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
